MARY RUTH - 3-in-1 DAILY GAS & BLOATING POWDER
MARY RUTH - 3-in-1 DAILY GAS & BLOATING POWDER, NPN 80147304: natural health product licensed in Canada. Medicinal ingredients: Bifidobacterium animalis subsp. lactis, Ligilactobacillus salivarius, Levilactobacillus brevis, Bifidobacterium animalis subsp. animalis.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium animalis subsp. lactis Source : BL-04 | 0.25 Milliards d'UFC | Not calculated |
| Ligilactobacillus salivarius Source : Ls-33 | 0.1 Milliards d'UFC | Not calculated |
| Levilactobacillus brevis Source : Lbr-35 | 0.1 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. animalis Source : Bi-26 | 0.1 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : BLC1 | 0.5 Milliards d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : GG | 2 Milliards d'UFC | Not calculated |
| Pediococcus acidilactici Source : Pediococcus acidilactici - Whole Cell | 1 Milliards d'UFC | Not calculated |
| Pediococcus acidilactici Source : KABP-021 | 1 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : KABP-022 | 1 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Lactiplantibacillus Plantarum - Cellule entière | 1 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : KABP-023 | 1 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : DR7 | 1 Milliards d'UFC | Not calculated |
| Lactobacillus sakei Source : proBio 65 | 13 mg | Not calculated |
| Lactococcus lactis Source : Lactococcus lactis - Cellule entière | 33.5 Milliards d'UFC | Not calculated |
| Lactococcus lactis Source : LI-23 | 33.5 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : BPL1 | 10 mg | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : CECT 8145 | 10 mg | Not calculated |
| Lacticaseibacillus paracasei Source : Lpc-37 | 3 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Lpc-37 | 1.8 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Lactiplantibacillus Plantarum - Cellule entière | 1.8 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Bifidobacterium bifidum - Cellule entière | 1.8 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : BB-06 | 1.8 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : Bifidobacterium breve - Cellule entière | 0.1 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : Bb-18 | 0.1 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : Bifidobacterium longum subsp. longum - Cellule entière | 2 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : BL-05 | 2 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Lactobacillus acidophilus - Cellule entière | 2 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : LA-14 | 2 Milliards d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : HN001 | 1 Milliards d'UFC | Not calculated |
| Lacticaseibacillus casei Source : Lc-11 | 2.5 Milliards d'UFC | Not calculated |
| Limosilactobacillus reuteri Source : LR100 (PBS072) | 0.25 Milliards d'UFC | Not calculated |
| Lactobacillus gasseri Source : LG050 | 3 Milliards d'UFC | Not calculated |
| Acacia Source : Senegalia Senegal - Gum | 145 mg | Not calculated |
| Gomme de Guar partiellement hydrolysée Source : Partially hydrolysed guar gum | 140 mg | Not calculated |
Non-medicinal ingredients
Phosphate de potassium monobasique, L-Cystéine, Extrait de tiges/feuilles de Bambusa vulgaris, Phosphate de dipotassium, Chlorure de sodium, Maltodextrine, Ascorbate de sodium, Citrate de sodium, Sucrose, D-Mannitol, Trehalose, Carbonate de magnésium, Dextrose, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Portions | 1 Tous les jours |
Uses authorised in Canada
Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics. Helps to improve gut-related stress/discomfort in 6 weeks. Help improves quality of life in patients with diarrhea-predominant irritable bowel syndrome. Helps improve quality of life by relieving IBS symptoms. Helps reduce symptoms of lactose intolerance such as abdominal pain and flatulence. Helps relief symptoms of irritable bowel syndrome (IBS). Helps improve IBS-related quality of life in patients with IBS and diarrhea. Helps relieve the symptoms of irritable bowel syndrome (IBS) (abdominal pain, bloating, distension). Helps to manage patients' IBS symptoms that impacts their quality of life. Helps improve quality of life in IBS patients by supporting gut health and improving gut comfort. Helps to improve IBS gut-related stress/discomfort in 6 weeks. Supports a healthy lifestyle. Supports antioxidant capacity. Helps support a healthy digestive tract and healthy gut microflora. Helps support gut microbiome diversity. Provides live microorganisms that contribute to healthy digestive tract flora. Probiotic that contributes to healthy digestive tract flora. Probiotic that naturally forms part of the digestive tract flora. Provides live microorganisms that naturally form part of the digestive tract flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contra-Indications
Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment). Do not use this product if you are taking clindamycin.
- Cautions and Warnings
Ask a health care practitioner/health care provider/health care professional/doctor /physician before use if you have fever, vomiting, bloody diarrhoea or severe abdominal pain Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms of digestive upset (e.g. diarrhea) occur, worsen and/or persists beyond 3 days. Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Product record
- Licence holder
- Les Emballages Façoteck
- NPN or DIN-HM
- 80147304
- Status
- Active licence
- Licence date
- 12 February 2026
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80147304
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “MARY RUTH - 3-in-1 DAILY GAS & BLOATING POWDER (Les Emballages Façoteck): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80147304-mary-ruth-3-in-1-daily-gas-bloating-powder, updated 12 February 2026.